Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration
Figure 4
Correlation plot showing correlation between aqueous VEGF (a) and aqueous IL-6 levels (b) with central subfield thickness on Spectralis OCT in patients in group 1.
